Efficacy of rizatriptan 10 mg administered early in a migraine attack

Headache

Volumn 46, Issue 6, 2006, Pages 914-924

  Cady, Roger ^a   Martin, Vincent ^b   Mauskop, Alexander ^c   Rodgers, Anthony ^d   Hustad, Carolyn M ^d   Ramsey, Karen E ^d   Skobieranda, Franck ^d  

^a Primary Care Network   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c New York Headache Center   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Early treatment; Efficacy; Migraine; Rizatriptan

Indexed keywords

PLACEBO; RIZATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNITED STATES; XEROSTOMIA;

ACUTE DISEASE; ADULT; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIGRAINE DISORDERS; PATIENT SATISFACTION; SEROTONIN AGONISTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRIAZOLES; TRYPTAMINES;

EID: 33646915680     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00466.x     Document Type: Article

References (21)

1. Cady RK, Sheftell F, Lipton RB, O'Quinn S, Jones M, Putnam DG, et al. Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials. Clin Ther. 2000 22:1035 1048.
2. Cady RK, Lipton RB, Hall C, Stewart WF, O'Quinn S, Gutterman D. Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum Study. Headache. 2000 40:792 797.
3. Pascual J, Cabarrocas X. Within-patient early versus delayed treatment of migraine attacks with almotriptan: The sooner the better. Headache. 2002 42:28 31.
4. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ, et al, International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia. 2000 20:765 786.
5. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000 55:754 762.
6. Dowson AJ, Sender J, Lipscombe S, Cady RK, Tepper SJ, Smith R, et al. Establishing principles for migraine management in primary care. Int J Clin Pract. 2003 57:493 507.
7. Geraud G, Lanteri-Minet M, Lucas C, Valade D. French Society for the Study of Migraine Headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther. 2004 26:1305 1318.
8. Winner P, Mannix LK, Putnam DG, McNeal S, Kwong J, O'Quinn S, et al. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. Mayo Clin Proc. 2003 78:1214 1222.
9. Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: Results of a multicenter, randomized, placebo-controlled study. Clin Ther. 2004 26:214 223.
10. Klapper J, Lucas C, Rosjo O, Charlesworth B; ZODIAC study group. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild. Cephalalgia. 2004 24:918 924.
11. Cady R, Elkind A, Goldstein J, Keywood C. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe. Curr Med Res Opin. 2004 20:1465 1472.
12. Brandes JL, Kudrow D, Cady R, Tiseo PJ, Sun W, Sikes CR. Eletriptan in the early treatment of acute migraine: Influence of pain intensity and time of dosing. Cephalalgia. 2005 25:735 742.
13. Mathew NT, Kailasam J, Fischer A. Early intervention using rofecoxib alone, rizatriptan alone and combination of rizatriptan and rofecoxib in acute migraine. Cephalalgia. 2001 21:425 abstract #P2-K45 Mathew NT, Kailasam J, Seifert T. Early treatment of migraine with rizatriptan: A placebo-controlled study. Neurology. 2004 62:A183.
14. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004 24 suppl 1 9 160.
15. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics. 1985 41:361 372.
16. Ferrari MD. Should we advise patients to treat migraine attacks early: Methodologic issues. Eur Neurol. 2005 53 suppl 1 17 21.
17. Ware JE, Bayliss MB, Kosinski M, Tepper S, Dowson A, Diamond M, et al. Accuracy of the headache impact test for migraine case finding. Cephalalgia. 2000 20:305 abstract #96 Ferrari MD, Loder E, McCarroll KA, Lines CR. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia. 2001 21:129 136.
18. Scholpp J, Schellenberg R, Moeckesch B, Banik N. Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia. 2004 24:925 933.
19. Mathew NT. Early intervention with almotriptan improves sustained pain-free response in acute migraine. Headache. 2003 43:1075 1079.
20. Dowson AJ, Massiou H, Lainez JM, Cabarrocas X. Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Headache. 2004 44:318 322.
21. Foley KA, Cady R, Martin V, Adelman J, Diamond M, Bell CF, et al. Treating early versus treating mild: Timing of migraine prescription medications among patients with diagnosed migraine. Headache. 2005 45:538 545.